GTC
OLMA icon

Ghost Tree Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Ghost Tree Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$6.39M Sell
535,000
-15,000
-3% -$192K 1.93% 22
2024
Q2 		$5.95M Buy
550,000
+350,000
+175% +$3.8M 1.86% 22
2024
Q1 		$2.26M Buy
+200,000
New +$2.58M 0.63% 52

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Ghost Tree Capital's OLMA Position: Q3 2024 in Review

Ghost Tree Capital reduced its Olema Pharmaceuticals (OLMA) stake by 2.7% in Q3 2024, selling an estimated $192K and leaving 535,000 shares worth $6.39M. The position accounts for 1.93% of the portfolio, ranked #22.

Ghost Tree Capital first reported a position in OLMA in Q1 2024 and has held it in 3 quarters since. 130 funds tracked by Wall St. Rank hold OLMA as of Q3 2024.

  • Ghost Tree Capital held 535,000 shares of Olema Pharmaceuticals worth $6.39M as of Q3 2024.
  • Ghost Tree Capital sold 15,000 Olema Pharmaceuticals shares in Q3 2024, an estimated $192K.
  • Olema Pharmaceuticals made up 1.93% of Ghost Tree Capital's portfolio in Q3 2024, its #22 holding.
  • Ghost Tree Capital first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • 130 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.